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Summary 
Elf-1 is an Ets family transcription factor that regulates a number of inducible lymphoid-specific 
genes, including those encoding interleukin 3  (IL-3), granulocyte/macrophage colony-stimu- 
lating factor (GM-CSF), and the IL-2 receptor (IL-2R) ot chain. A  minimal oligonucleotide 
spanning the IL-21kot Elf-1 site (-97/-84)  bound Elf-1 poorly, but binding activity markedly 
increased when this oligonucleotide was mnltimerized or flanking sequences were added. This 
result is consistent with the requirement of accessory proteins for efficient Elf-1 binding, as has 
been demonstrated for the GM-CSF and IL-3 promoters. A binding site selection analysis re- 
vealed the optimal Elf-1 consensus motif to be A(A/t)(C/a)CCGGAAGT(A/S), which is sim- 
ilar to the consensus motif for the related Drosophila E74 protein. This minimal high affinity 
site could bind Elf-1 and functioned as a stronger transcription element than the -97/-84  IL- 
2Rc~ oligonucleotide when cloned upstream of a heterologous promoter. In contrast, in the 
context of the IL-2Rcx promoter, conversion of the naturally occurring low affinity Elf-1 site 
to an optimal site decreased inducible activation of a reporter construct in Jurkat  cells.  This 
finding may be explained by the observation that another Ets family protein, ERGB/Fli-1,  can 
efficiently bind  only to  the  optimal  site,  and in  this  context, interferes with Elf-1  binding. 
Therefore, high affinity Elf-1 sites may lack sufficient binding specificity,  whereas naturally oc- 
curring low affinity sites presumably favor the association of Elf-1 in the context of accessory 
proteins. These findings offer an explanation for the lack of optimal sites in any of the known 
Elf-l-regulated genes. 
T 
ile  ets  gene  family  encompasses  a  variety  of DNA 
binding proteins involved in cellular growth and dif- 
ferentiation. Aberrant expression of some members of this 
family have been implicated in cellular transformation (for 
reviews see references l-3). All Ets family proteins contain 
a conserved DNA binding "Ets" domain comprising adja- 
cent o~-helical and basic  domains that is referred to as the 
Ets domain. The location of the Ets domain varies within 
members of this family, but regardless of location the Ets 
domain mediates binding to the core nucleotide sequence 
GGAA/T (2). Ets family proteins can be classified based on 
the structures of their Ets domains, with each subgroup dis- 
playing subtle  differences in DNA  binding specificity (4). 
The binding and transactivation of some Ets family proteins 
have been shown to be influenced by the binding of acces- 
sory proteins (5-13). Whereas some Ets family of proteins 
are ubiquitously expressed, others exhibit cell type-specific 
expression. 
Elf-I is an Ets family member whose expression is rela- 
tively restricted  to  lymphoid and  myeloid cells  (14).  Al- 
though Elf-1  was  identified by low stringency hybridiza- 
tion using a probe from the basic domain of human Ets-1, 
its Ets domain is most similar to that of the Drosophila E74 
Ets family protein (14). Elf-1 can bind the underphospho- 
rylated form of the retinoblastoma gene product (Rb) (15), 
so that during T  cell activation, the phosphorylation of Rb 
results  in the release of Elf-l,  temporally correlating with 
the  expression of Elf-1  regulated genes.  Binding sites  for 
Elf-1 have been identified in the promoters of a variety of 
important lymphoid-specific genes including those encod- 
ing IL-3 (5), GM-CSF (6), CD4 (16), and IL-2R~x  (17), as 
well as in the long terminal repeats of the T  cell tropic vi- 
ruses  HIV-2  (18)  and human T  cell lymphotropic virus I 
(HTLV-I) (19). 
We have demonstrated that the IL-2Rcx Elf-1 site is es- 
sential for transcriptional activation of this gene and estab- 
lished IL-2R0~  as the first  example of a gene in which an 
enhancer  (positive regulatory region  II;  17)  can  be  acti- 
vated by overexpression of Elf-1  and an accessory protein, 
the high mobility group protein (HMG-I) (17). It is interest- 
ing to note that Elf-1 exhibited essentially  no binding to an 
oligonucleotide  (-97  to  -84  of the  IL-2R_o~ promoter) 
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flanking nucleotides identified by methylation and ethyla- 
tion  interference  analyses.  However,  it  avidly  bound  a 
larger fragment,  indicating  that Elf-1  binding was  depen- 
dent on additional  sequences and/or accessory proteins.  A 
binding site selection analysis defined a 12-nucleotide con- 
sensus motif spanning a  GGAA core motif as  the  optimal 
Elf-1  site.  It is  interesting  to note that  the  -97/-84  IL- 
2Rot oligonucleotide lacks two of the highly conserved nu- 
cleotides,  explaining  its  poor Elf-1  binding activity.  Con- 
version of the naturally occurring, lower affinity Elf-1 site 
in the IL-2Rot promoter to an optimal site resulted in a de- 
crease  in  inducible  transcriptional  activity.  We  show  that 
the  ets family protein,  ERGB/FIi-1  can bind  only to  the 
high  affinity  site  and  can  efficiently  interfere  with  Elf-1 
binding in this context.  Therefore, high attinity Elf-1  sites 
may  lack  sufficient  binding  specificity  to  allow  carefully 
controlled  Elf-l-mediated  gene  regulation.  These  studies 
suggest that the absence of naturally occurring high affinity 
Elf-1  sites  in Elf-I  regulated  genes could be a mechanism 
to achieve greater inducibility  and underscore  the  impor- 
tance of accessory proteins in modulating Elf-1 binding and 
action. 
Materials and Methods 
Electrophoretic Mobility  Shift Assays  and Methylation and Dieth- 
ylpyrocarbonate Inte[ferenceAssays.  Binding  reactions  (final vol- 
ume, 20 Izl) contained 2 Ixl of in vitro translated proteins or 3 Ixl 
ofa 1 : 10 dilution of Sf9 insect cell extracts  (control or Elf-1 pro- 
grammed),  10,000-40,000  cpm of probe  (0.1--0.3 ng), 2 p,g of 
poly(dl-dC), in  10 mM Tris HC1,  pH 7.5,  10 mM Hepes,  50 
mM KC1, 1.25 mM dithiothreitol, 1.1 mM EDTA, 15% glycerol, 
and  1 mg/ml acetylated  BSA for reactions  with insect cell  ex- 
tracts.  Electrophoretic mobility shift assays (EMSAs) 1 were per- 
formed as previously described  (17). For methylation and DEPC 
interference assays, binding reactions  (final volume, 60 p,1) con- 
tained 25  Ixl of Elf-1  programmed lysate,  7 p,g of poly(dI-dC), 
and 3 X 10  s cpm of probe, and were performed as described  (17). 
Oligonucleotides, Plasmids, and In Vitro Mutagenesis.  Oligonucle- 
otides were synthesized on a DNA/RNA synthesizer (model 392; 
Applied Biosystems,  Inc., Foster City, CA). The IL-2R~x -97 to 
-74 (5'-agcttCACTTCCTATATTTGAGATGAGAGg-3')  and 
3)<  (-97/-84)  (5'-agcttCACTTCCTATATTTCACTTCC- 
TATATTTCACTTCCTATATTTg-3')  oligonucleotides  were 
synthesized with HindlII and BamHl overhangs.  The oligonucle- 
otides depicted (see Figs. 3 A  and 4 A) had HindllI- and XbaI- 
compatible ends and were cloned between these sites in pBLCAT2. 
The mutant  IL-2R~x construct  (IL-2Ret m2) was generated by 
PCR mutagenesis  (20).  The sequence  on the top strand  of the 
wild-type (WT) and mutant -137/-64 m2 oligonucleotides  used 
in  EMSAs are  as follows:  -137/-64  WT  5'-agcttACCGCA- 
AACTATATTGTCATC  (A)lgCACTTCCTATATTTGAGA- 
TGAGAGAAGAGAGTGCg-3'  -137/-64  m2  5'-agcttAC- 
CGCAAACTATATTGTCATC  (A) 19CACTTCCGGTATTTG 
AGATGAGAGAAGAGAGTGCg-3'. 
Binding Site Selection.  A  Myc  epitope  tag  (21) was  inserted 
into the Elf-1 cDNA between amino acids 5 and 6 by PCR mu- 
1Abbrevations used in this  paper: EMSA, electrophoretic mobility shift assay; 
WT, wild type. 
tagenesis  (20);  this  Myc-tagged Elf-1  ("Elf-tag")  construct was 
cloned into pcDNA I/Amp (Invitrogen,  San Diego, CA) between 
the EcoRV and XhoI sites, and correctness  was verified by DNA 
sequencing. A binding site selection  assay (22) was performed us- 
ing a pool ofoligonucleotides containing a central core of 26 ran- 
dom nucleotides.  After the binding of in vitro translated  Elf-tag 
protein,  sequences  that could bind Elf-1  were imrnunoprecipi- 
tated with 9El0, an anti-Myc mAb (21), and amplified  by PCR. 
After four rounds of selection,  DNA was gel purified and ana- 
lyzed by DNA sequencing. 
Expression and Purification of Elf-1 In Insect Cells.  We  first con- 
structed a versatile baculovirus expression vector, pVLH6Plink, that 
contains a polylinker  to facilitate cloning of a cDNA insert. When 
expressed  in  Sf9  cells, pVLHrPlink  directs  production  of the 
cDNA-encoded peptide  as a fusion protein containing a run of 
six  histidines  at  the  NH  2 terminus  (R.  Marais,  manuscript  in 
preparation).  The 1.9-kb NcoI to XbaI human Elf-1 cDNA frag- 
ment  from pEF-Elf-lplink  (S. John,  unpublished  observations) 
was inserted  between the  NcoI and XbaI sites of pVLI-IrPlink. 
The resulting plasmid, pVLHrElf-1, was used to prepare an insect 
cell virus, denoted HrElf-I, using the Baculo-Gold kit (PharMin- 
gen, San Diego, CA) as a source oflinearized viral genomic DNA. 
The expressed  HisrElf-1  fusion protein was purified using Ni  2+ 
affinity  chromatography. To  generate  a  control virus,  we  used 
pVLH6-AS-SAP-1, in which the Ets family protein SAP-1  (13) 
was cloned in an antisense  orientation  (R.  Marais,  unpublished 
observations).  Sf9 insect cells were propagated and viral infection 
performed as previously described  (23), except that the cells were 
grown in Ss 900-II defined medium supplemented with antibiot- 
ics. Cell extracts were prepared as described (23). 
Cell Lines, Transfections, and CA T Assays.  Jurkat E6.1 cells were 
maintained in RPMI 1640 medium supplemented with 10% fetal 
bovine serum  (Biofluids,  Inc.,  Rockville,  MD),  penicillin  (100 
U/ml), streptomycin (100 U/re_l), and glutamine (2 re_M). Trans- 
fections were performed by the DEAE-dextran method (17). Af- 
ter transfection,  cells were maintained in 2% fetal bovine serum 
and then were either left untreated or treated with PMA (20 ng/ml; 
Calbiochem-Novabiochem Corp., La Jolla, CA) for 12-15 h. CAT 
assays were performed as described  (17) using equal  amounts of 
protein in each assay. 
Results  and Discussion 
Identification of a  Consensus Motif  for  Optimal Elf-1  Binding. 
We have demonstrated that Elf-1 regulates transcription of 
the  IL-2Rot gene and contacts the  -97  to  -84  sequence 
(5'-CACTTCCTATATTT-3'  top  strand;  5'-AAATAT- 
AGGAAGTG-3'  bottom  strand;  GGAA  Ets  core  motif 
underlined)  in the IL-2Rot promoter in positive regulatory 
region II (PRRII) (17). It is interesting to note that an oli- 
gonucleotide comprising only this region (Fig. 1 A, lane 2) 
bound Elf-1  weakly, whereas  a trimer  of this region  (lane 
4) or a longer oligonucleotide (-97 to -74, lane  6) exhib- 
ited greater Elf-1  binding.  To clarify Elf-1  binding nucle- 
otide preferences, we used a binding site selection method 
(22). As expected, no complex was detected when the ini- 
tial  random pool of oligonucleotides  was  used  as  a  probe 
(Fig.  1 B, lane  I), but after two or more rounds of selec- 
tion,  two  specific  complexes  were formed with  the  Elf-1 
cRNA programmed lysate (lanes  3-5) but not with unpro- 
grammed  lysate  (lane  6).  The  slower  mobility  complex 
744  Low Affinity Elf-1 Regulates  Inducible Lymphoid-specific  Genes Figure 1.  Selection of  optimal Elf-1 binding sites. (A) The -97 to -84 IL-2Rcx  oligonucleotide  binds poorly to Elf-1. EMSAs were performed with 
unprogrammed (lanes 1, 3, and 5) or Elf-I programmed lysate (lanes 2, 4, and 6) and 32p-dCTP-labeled -97/-84 (lanes 1 and 2), 3X (-97/-84) (lanes 
3 and 4) and -97/-74 (lanes 5 and 6) oligonucleotide  probes. The positions of the specific Elf-1 complexes  are indicated. (B) EMSAs of  selected Elf-1 
binding sites. EMSAs were performed with Elf-1 programmed lysate and the pool of oligonucleotides before (lane 1) or after one (lane 2), two (lane 3), 
three (lane 4), and four (lane 4) rounds of selection. Unprogrammed lysate showed no binding to the selected pool of oligonucleotides even after four 
rounds of selection (lane 6) (C) EMSAs were performed with oligonucleotides  containing CCGGAA (nos. 20 and 85), CAGGAA (no. 78), and ACG- 
GAA (no. 53) selected sequences (see Table 1). Probes were labeled to similar specific activities and incubated with 3 I~1 of  a 1 : 10 dilution of control ly- 
sate prepared from Sf9 insect cells infected with an empty vector (lanes 1-4) or crude lysate prepared from Elf-l-infected insect cells (lanes 5-8). The Elf- 
1-specific complex is indicated. 
comigrated with the complex formed with nuclear extracts, 
whereas the faster mobility complex appears to result from 
degradation  of Elf-1  (17).  DNA  from  each  complex was 
cloned into pBluescript.  Of the 50 clones derived from the 
slower  mobility  complex,  49  contained  a  GGAA  motif, 
with  one  of these  having  two  GGAA  motifs  (Table  1). 
Alignment  of the  48  sequences  containing  a  single  motif 
(Table  1,  Consensus)  revealed  C  residues  were  present  in 
98  and 94%,  respectively,  of the sequences  at the  -2  and 
-1  positions,  and a preference for a  C  at the  -3  position 
and  A  at  the  -4  and  -5  positions.  Downstream  of the 
GGAA motif, a G  at position  +1, a T  at position  +2, and 
an  A,  G,  or  C  at position  +3  were  preferred.  Thus,  the 
consensus motif for optimal Elf-1  binding was 5' AA/tC/ 
aCCGGAAGTa/g/c-3'. 
To confirm that the selected sequences could bind Elf-l, 
probes that encompassed much of the sequence variation of 
the selected clones (CCGGAA [nos. 20 and 85], CAGGAA 
[no. 78], and ACGGAA [no. 53]  core sequences;  Table  1) 
were  tested  in EMSAs  using extracts  from insect  cells  in- 
fected with a control empty virus or with a virus encoding 
Elf-1  containing six histidines at its NH 2 terminus  (H6Elf-1, 
Fig.  1  C).  H6Elf-1  formed specific complexes with all four 
probes  but  not with  a  probe  derived  from clone  21  (data 
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not shown), which lacks an Ets binding motif (Table 1) and 
whose  selection  probably resulted  from nonspecific  bind- 
ing.  Similar  results  were  obtained  with  in  vitro  translated 
Elf-l,  whereas  unprogrammed lysate did not form specific 
complexes (data not shown).  Clone 85 exhibited the high- 
est binding activity for H6Elf-1  (Fig.  1  C,  lane  8),  consis- 
tent with this clone containing the preferred nucleotides at 
all positions  (Table  1).  Clones 78,  53,  and 20  (which con- 
tain  A's  at  the  -1,  -2,  and  +2  positions,  respectively) 
each exhibited less binding than did clone 85  (lanes 5-7 vs. 
8),  suggesting that  C's at  -1  and  -2  and  a  T  at  the  +2 
position are required for optimal Elf-1 binding.  In addition 
to the Elf-l-specific  complex formed with probe  53,  two 
faster mobility complexes were observed (lane  6), but these 
were also formed with  the  control mock-infected extracts 
(lane 2) and therefore were not Elf-1 specific. 
Identification  of the  Nudeotides  Contacted by  Elf-1  in  the 
Consensus Motif.  To  determine  which  nucleotides  were 
contacted by Elf-l, we performed methylation and carbox- 
yethylation  interference  analyses  using  clone  85,  which 
contains the high affinity Elf-1 binding sequence, 5'-AAC- 
CCGGAAGT-3'.  Methylation  interference  analysis  re- 
vealed  strong  protection  of the  GGAA  core  on  the  top 
strand and the A  at the  +2 position on the bottom strand Table  1.  Selected  Binding Sites  for Elf-1 
CCGGAA 
1  CAGCTCCTGGTACC 
2  TGTCTTTCACAGTGTACC 
3  CACATAACCC 
5  AGCCC 
6  CC 
7  AACC 
8  GATTATCCC 
9  ACAACTGCCTCACTTCC 
10  AGCCC 
11  AACC 
12  TTACCC 
14  ATTAACCCTCCACTTCC 
15  AACCC-GGGG~CAGCCC 
16  CC 
17  CCGGCTTCC 
18  CC 
19  CC 
20  CAACCGACGAACCC 
22  TCAAGCAACCCCTTAACCC 
23  ACCAATCCC 
28  TTAACAAAACCC 
29  ACCGCGACC 
41  AACCC 
43  TTAGTGCTGACCCC 
48  ACCCC 
49  TTAAAAACCC 
50  CATCCC  ~A~ 
51  ACCGCGACC  ~GA~ 
54  AAC  CGGGGGGCAGC  C  C  ~A~ 
55  ACAGCTAGTCCATAACCC  ~A~ 
56  CGTTTAAACAGTAAACC  ~A~ 
57  CC  ~A~ 
58  CCTCTCTCATTAACC  )GAA 
60  TGTTCCTCGGACCC  ~GAA 
62  CGCAACGAAAAGCC  )GAA 
65  ACCTTAACCC  )GAA 
66  TTAAAAGCCC  ~AA 
68  ATAGCAAACCC  :GAA 
71  TCTCTTTCACAGTGTACC  ~AA 
72  ATGATGTTTCTCAGTGTACC  ~AA 
80  TTAAAAACCC  ~GAA 
83  GACCC  ~AA 
85  TAAACCC  ~AA 
86  CCGCCCC  ~AA 
CAGGAA 
33  TAAGTTGATTCA  ~AA 
52  ACCAGGAAGGATTCA  ~GAA 
78  CAAACCA  ~GAA 
ACGGAA 
53  C  GTTTAAACAGTAAAC  ;GAA 
Double  Site 
)GA~ GTACAAT 
~A~ GTGA 
~3A~ ~GAGTCAAACAC 
~A~ ~TATCACC  TTTAGATGA 
~GA~ ~TGTAAGAAAltAC  C  TCGGT 
~GA~ GTTACGAAAGATGCCGAC 
~GA~ ~CCGCGCTCCATT 
~A~ ~GGCT 
~A~ ~TATCACCTTTAGATGA 
:GA~ ~TAATCAATGACAGTTC 
~A~ 3TTGGGTTGATTTGGC 
~GA~ ~CCGG 
~A/DGTAAT 
~GA~ DTCC  C  CCCGTCAAAGTTTAAC 
~GA~ ~TGGAGGGTTAAT 
~A/DTCCCCCGTGAAAGTTTAAC 
~A~ ~TGTTAAGAAAAACC  TCGGT 
~GA~ ~AGAGTAT 
~GA~ ACA 
;GA~ 3CCCAACC  TTAAT 
~GA~ ~ACATCTACA 
:GA~ 3TACCCTTAGTA 
~AA KTCTTGATAGAGCACC 
:OAA ~TAGTTAA 
;GAA 3TTTAGCTTTACATAG 
~A~ DGAAGACACATC 
KTGCAGAAGTCCGAA 
~TACCCTTAGTA 
~TAAT 
~TCA 
~TGTG 
DTGGCGCTAACACAAAGTTA 
3TATAAG 
3TTAGTGA 
3TATACC 
3TAAATCCTGTC 
~TCTATGTACCA 
DACAACTATCA 
3TGA 
3T 
~GAAGACACATC 
DCAAACTTACCATGCTG 
3TGTAGTACATCT 
3TACCCTGACGA 
3AGTAAACAG 
2TAATCC 
~TTAAAGCAACTCTG 
DTGTG 
44  TGC~TGCTTATC~T 
No GGAA  motif 
21  GTC  TAGTAATATAGCAC  TCGTTATAA 
-5  -4  -3  -2  -i  G  G  A  A  1  2  3 
A  25  21  11  1  3  48  48  3  5  18 
G  7  7  1  48  48  44  5  13 
C  5  3  26  47  45  1  5  10 
T  3  12  5  33  6 
Consensus  Elf-I  binding  site: 
5  ) A  A  t  C  a  C  C  G  G  A  A  G  T  a  s  3' 
The sequences  of the selected  oligonucleotides are  depicted with the 
conserved Ets motif GGAA (boxed). The Elf-1 consensus motif (bottom) 
was  derived  from  48  sequences  containing  a  single  GGAA binding 
core; the frequency of each nucleotide used to generate the consensus is 
shown.  At positions  -4  and  -3,  the more favored nucleotide is de- 
picted in uppercase  and the second most favored residue  in lowercase. 
At position  +3, A, G, and C residues were selected at approximately  the 
Figure  2.  Analysis  of Elf-1 interaction  with clone 85 by methylation 
(A) and ethylation  (B) interference  assays. (A) Complexes  between Elf-t 
and  partially methylated  endlabeled  probes  from  clone 85 were purified 
from a native gel, cleaved by piperidine  and the bound (lanes I and 3) and 
free (lanes 2 and 4) probes were resolved on a 9% denaturing  gel. (B) Par- 
tially ethylated,  endlabeled  probes  from clone 85 were analyzed as in A. 
Lanes  1 and 3 show migration of the free probe, whereas the results of the 
bound probes are shown in lanes 2 and  4. In both A and B, solid circles 
indicate nucleotides  that are strongly protected  and open circles indicate 
weakly  protected  nucleotides.  (C)  Summary  of the  methylation  and 
I)EPC interference analyses depicted  in A and B. 
(Fig. 2 A, closed circles). It is interesting that the G's on the 
bottom  strand  (corresponding  to  the  conserved  C's  at  the 
-1  and  -2  positions)  were not protected.  Nevertheless,  it 
is  conceivable  that  important  contacts  could  exist  (such  as 
the possibility of Elf-1  contacting the conserved C's in the 
major groove) that are not readily detected by the methods 
we  have  used.  Carboxyethylation  studies  confirmed  some 
of the results obtained with methylation interference analy- 
sis  and  additionally  revealed strong  protection  of the  G  at 
+1,  the A  at  -4  (Fig.  2  B, solid circles),  and  weak protec- 
tion of the A  at  -5  (Fig. 2  B, open circle). On  the bottom 
strand,  the A  at  +2  was  strongly  protected  (Fig.  2  B, solid 
circle)  and  the  G's  at  -1  and  -3  (Fig.  2  B,  open  circles) 
were  weakly  protected.  These  results  are  summarized  in 
Fig. 2  C. 
A  Minimal  Consensus  Oh[gonucleotide  Can  Bind  E!f-l. 
The  IL-2P.ot  Elf-1  site  is  83%  identical  to  the  consensus 
same levels and are therefore represented  as a/s, where s =  G or C. All 
sequences  shown correspond to the strand  containing the GGAA core 
motif. 
746  Low Affini  W Elf-I Regulates Inducible Lymphoid-specific Genes Table 2.  Known Elf-1 Binding Sites (Top) and Comparison of 
Consensus Binding Sites  for Elf-I, E74, Fli-1, Ets-1, and Elk-1 
(Bottom) 
Percent 
identity to 
consensus 
Elf-1 site 
IL-2P,  lx* 
CD4 
GM-CSF 
IL-3 
HTLV-I LTR (PUB1) 
HTLV-I LTR (PUB2) 
HIV-2 LTP, (PUB1) 
HIV-2 LTP, (PUB2) 
% 
ATATAGGAAGTG  ,--,83 
AAACAGGAAGTC  ,-092 
TTAGAGGAAATG  ,-'-,67 
TGGCAGGAAGGG  ,--,58 
CCTCCGGAAGCC  ,--'67 
GGGGAGGAAATG  ~--,50 
AGACAGGAACAG  ~67 
GGGCAGGAAGTA  ~67 
A  A~  C~  C  C  GGAAG T As Elf-l* 
A  A  Y  CMGGAAGT  E74 
N R  A  C  C  GGAAGff,P. Fli-1 
t~  CM  GGAWRY  Ets-I 
a,  Y  C^CAGGAWT R  Elk-1 
(Top) IL-21kc~" refers to the  -97 to -84 region of the IL-2P,  a  pro- 
moter (17); the noncoding strand is shown so that the orientation cor- 
responds to the consensus shown in Table 1. The other Elf-1 sites are in 
the IL-3, GM-CSF, and CD4 enhancers, (5, 6, 16) and in the HIV-2 
(18) and HTLV-I (19) LTRs. Also shown are the percent identity of 
the known Elf-1 sites with the 12-nucleotide Elf-1 consensus shown in 
Table  1. (Bottom) The consensus binding sites for optimal binding of 
Elf-1 is compared with that of Ets-1 (24, 25) E74 (26), Fli-1 (27), and 
Elk-1 (30) are shown. The core Ets binding motif, GGA.A/T is indi- 
cated in bold typeface. 
Elf-1 site (Table 2). To clarify the basis for the lack of Elf-1 
binding to the  minimal  -97  to  -84  IL-2Rcx oligonucle- 
otide,  we assayed the ability of Elf-1  to bind to a series  of 
mutant  oligonucleotides  (Fig.  3 A).  Analogous to in vitro 
translated  Elf-1  (Fig.  1  A),  purified  recombinant  His6- 
tagged Elf-1 protein  did not bind to the  -97/-84  oligo- 
nucleotide (Fig. 3, B, lane  1), which lacks the consensus C 
at  positions  -1  and  -2.  Maximal  Elf-1  binding  activity 
was observed with m2, which contained C's at these posi- 
tions  (lane  3).  Mutant  ml,  which  has  a  C  at  -2,  bound 
Elf-1  weakly,  but  no significant binding activity was seen 
with m3, which contained a C  at  -1  (lanes 2 and 4),  con- 
firming that C's at both the  -1  and -2  positions are essen- 
tial for optimal Elf-1  binding.  The highly conserved A  at 
-5  was  also  important,  since  its  mutation  to  a  G  in  the 
context of the high affinity m2 oligonucleotide  (Fig.  3 A, 
m4), resulted in a large decrease in Elf-1 binding (Fig. 3 B, 
lanes  5  vs.  3).  No  binding  to  any probe  was  seen  when 
control  lysates  were  used  (lanes  6--10.  Therefore,  the  in- 
ability of Elf-1 to bind to the minimal  -97  to -84  IL-2Rcx 
oligonucleotide was due to the absence of the consensus C 
at positions  -  1 and  -2. 
747  John et al. 
High AfiTnity Elf-1  Sites Are Less Inducible than Suboptimal 
Sites.  We next compared the ability oflL-2R0~ -97/-84 
oligonucleotides to activate transcription when cloned up- 
stream  of the  TK promoter in pBLCAT2 and  transfected 
into Jurkat T  cells.  The optimal Elf-1 site (m2 mutant)  was 
a stronger transcriptional  element than the WT  -97/-84 
IL-21Lot suboptimal Elf-lbinding  site  (Fig.  3  C), suggest- 
ing that the extent of activation in vivo correlates with the 
level of Elf-1 binding in vitro. Mutants ml  and m3 (Fig. 3 
A)  were  transcriptionally  less  active  than  m2  (data  not 
shown). We next studied the ability of the high affinity Elf-1 
site  to function in the  context of the  -472  to  + 109 full- 
length  IL-2Rot promoter by transfecting WT  and mutant 
IL-2Roe constructs into Jurkat T  cells and assaying for tran- 
scriptional  activity  after  PMA  stimulation.  In  contrast  to 
our finding with the minimal -97  to -84  construct, in the 
full-length promoter setting,  conversion of the natural WT 
Elf-1  site to a high affinity Elf-1  (m2) site did not increase 
the basal promoter activity and was less inducible  than the 
WT promoter (Fig. 3 D).  The reason for the lower induc- 
ibility  of the  m2  mutant  is  likely  due  to  its  higher  basal 
level of Elf-1 binding observed in EMSAs usingJurkat nu- 
clear extracts (Fig. 3 E). An anti-Elf-1 antibody was able to 
supershift  the  upper  complex formed with  both  WT  and 
mutant oligonucleotides (Fig. 3 E). 
ERGB/Fti-1  Binds  Efficiently to a High Affinity Elf-1  Site 
and Can Inhibit Elf-1 Binding.  A  comparison  of the  con- 
sensus sites  for Elf-l, Ets-1  (5'-RCMGGAWRY-3';  refer- 
ences 24 and 25), E74 (5'-AAYCMGGAAGT-3'; 26), and 
Fli-1  (5'-NG/AACCGGAAG/aT/cA/G-3';  27)  (see  Ta- 
ble 2) revealed that as expected, the binding specificities for 
Elf-1  and E74 sites  are more similar to each other than to 
the Ets-1  site.  It is surprising that the  optimal Elf-1  site  is 
very similar to that of another Ets family protein,  ERGB, 
or its  murine  homologue,  Fli-1  (both  contain  CCGGAA 
core sequences;  see Table 2),  even though these  two pro- 
teins belong to separate Ets protein subfamilies and contain 
only 46%  amino  acid  identity  in  their  Ets  domains.  Up- 
stream  of their  GGAA cores there  were  more  differences 
between the Elf-1  and ERGB/Fli-1  binding sites,  particu- 
larly at the  -5  position where there is an absolute require- 
ment for an A  for optimal Elf-1  binding (Fig. 3  B, mutant 
m4), whereas Fli-1 can accommodate any nucleotide at this 
position  (27).  We  therefore  hypothesized  that  one  of the 
reasons for the lower inducibility of the  IL-2RoL m2 pro- 
moter than  of the  WT  IL-2Ror  promoter  (Fig.  3  D)  may 
be  due  to  the  ability  of ERGB/Fli-1  to  also  bind  to  the 
high afffnity Elf-1  site,  preventing Elf-l-mediated  regula- 
tion of transcription.  Indeed,  whereas Elf-1  could bind to 
both  WT  and  m2  -137/-64  oligonucleotides,  in  vitro 
translated ERGB/Fli-1  only bound to the m2 oligonucle- 
otide (Fig. 4 A). We confirmed that ERGB/Fli-1  from nu- 
clear extracts was also able to bind to the high affinity Elf-1 
site  by performing DNA  affinity purification  using Jurkat 
nuclear extracts and a biotinylated 3X  (-97/-84  m2) oli- 
gonucleotide,  followed by Western  blot  analysis  using an 
anti-Fli-1  antibody  (data  not  shown).  Finally,  we  investi- 
gated  whether  Elf-1  and  ERGB/Fli-1  can  compete  with Figure 3.  Elf-1 binding to WT and mutant IL-2Rtx oligonucleotides.  (A) Sequences of the -97/-84  IL-2R~x oligonucleotides  used in B. The anti- 
sense strand of each oligonucleotide  is shown.  For ml, m2, m3, and m4, the mutated  nucleotides are underlined.  (B) Oligonucleotides  were end-labeled 
and diluted to similar specific activity and evaluated in EMSAs using purified recombinant His6-tagged Elf-1 protein that was produced in Sf9 insect cells 
(lanes 1-5) or control Sf9 cell lysates (lanes 6-10). The probes are indicated above each lane. The position of the Elf-1 specific complex is indicated.  (C) 
Jurkat cells were transfected with the control vector (pBLCAT2),  or constructs  containing  the WT or m2 -97/-84  IL-2Rtx  oligonucleotides  cloned 
upstream of TK-CAT in pBLCAT2. A representative experiment is shown.  Relative CAT activities from three independent experiments  normalized to 
the activity of pBLCAT2 in the absence of PMA, which was assigned a value of 1.0, were as follows: for uninduced cells pBLCAT2 (1,  1,  1); -97/ 
-84TKCAT (3.4, 1.9, 2.7); m2TKCAT (4.8, 5.8, 3.6); for induced cells, pBLCAT2 (1.2, 1.4, 1.2), -97/-84TKCAT (4.9, 2.7, 3.8), m2TKCAT (7.7, 
9.1, 8.1). (D) A high affinity Elf-1 site confers lower PMA-induced activity to the IL-2R.tx promoter. Sequence of the -97/-84 region of the WT and 
mutant  (m2) IL-2Rct promoter. The mutated  nucleotides are underlined  in IL-2Rot-m2. Jurkat E6.1 cells were transfected with control vector  Jymcat-0 
(J0) or with WT or m2 IL-2tkct constructs. Data represent the mean +  standard error of the mean of three  (for J0) or four (for WT or IL-2tket m2) in- 
dependent  experiments.  The activity of  J0 without PMA treatment  was assigned a value of 1.0; the activities of other constructs are expressed as relative 
fold increases over J0 activity. (Open bars) No PMA treatment;  (solid bars) PMA treated.  (E) EMSAs were performed  with 5 p,g of nuclear extracts pre- 
pared from PMA-activated Jurkat  cells that were incubated with no antibody  (lanes 1 and 3) or 1 p~l of an anti-Elf-1 mAb (17) (lanes 2 and 4) before in- 
cubation with 32p-labeled WT (lanes 1 and 2) or m2 (lanes 3 and 4) -137/-64 IL-2R~t oligonucleotides.  (Arrow)  Supershifted Elf-1 complex. 
each other for binding by performance EMSAs with a fixed 
amount  of Elf-1  and  increasing  amounts  of ERGB/Fli-1 
(Fig. 4  B, lanes 2-6)  or a  constant  amount  of ERGB/Fli-1 
and increasing amounts  of Elf-1  (lanes  8-12).  The binding 
of Elf-1  or ERGB/Fli-1  alone  are shown  in lanes  1 and  7, 
respectively.  Whereas  both  Elf-1  and  ERGB/Fli-I  could 
compete  with  each  other  for  binding,  ERGB/Fli-I  was 
more  effective at  displacing Elf-l,  suggesting  that  it  could 
bind  with  higher  affinity  to  the  -137/-64  m2  site  than 
Elf-1. 
In Jurkat T  cells, ERGB/Fli-1  is constitutively expressed 
(our unpublished  observations).  Thus,  the lower inducibil- 
ity  observed  in Jurkat  cells when  the  normal  Elf-1  site  in 
the IL-2Rct promoter was replaced with a high affinity Elf-1 
site  could be  due  to  impaired  regulation  of the  promoter 
resulting from competition between Elf-1  and ERGB/FIi-1 
for the  same  site.  Analogously,  we  have  found  that  muta- 
tion of the GM-CSF  PB1  enhancer  (6)  so that it now  con- 
tains a high affinity Elf-1 site, results in a loss of the require- 
ment for a  cooperating AP-I  site for its functional  activity, 
but  displays  reduced  levels of inducibility when  compared 
to  its  normal  counterpart  (data  not  shown).  These  studies 
suggest that the loss of fine DNA  binding specificity associ- 
ated with a high affinity site, could cause serious dysregula- 
tion  of gene  expression  in  a  normal  T  cell  environment, 
where a number of expressed Ets family proteins could po- 
tentially bind to the high affinity site. 
Whereas Ets-1  and Ets-2  can utilize a  GGAA  or GGAT 
748  Low Affinity Elf-1 Regulates Inducible Lymphoid-specific Genes Figure 4.  ERGB/Fli-1 can compete with Elf-1 for binding to the high affinity m2 Elf-1 site but cannot bind the WT IL-2R~t Elf-1 site. (A) EMSAs 
were performed with unprogrammed (lanes 1 and 4), ERGB (lanes 2 and 5) or Elf-1 (lanes 3 and 6) progranuned lysates and 32p-labeled WT (lanes 1-3) 
or m2 (lanes 4-6)  -137/-64 IL-2Rct oligonucleotides. (B) EMSAs were performed with 32p-labeled -137/-64 m2 oligonucleotide and 1.5 I~1 of in 
vitro translated Elf-1 protein (lanes 1-6) or ERGB protein (lanes 7-12). In lanes 2-6 and 8-12, increasing  amounts of  in vitro translated ERGB or Elf-1 
protein were added, respectively. The total amount oflysate added in each lane was kept constant by adding unprogrammed rabbit reticulocyte lysate. 
core,  Elf-l,  E74,  and  ERGB/FIi-1  have  an  absolute  re- 
quirement  for  a  GGAA  motif.  The  difference  in  DNA 
binding  specificity  between  Elf-I/E74  and  Ets-1/Ets-2  is 
consistent with the greater similarities of the Elf-1 and E74 
Ets domains (4,14), and was shown to result from the pres- 
ence ofa threonine in Elf-1 and E74 versus a lysine in Ets-1 
and Ets-2 proteins in an otherwise highly conserved 11-resi- 
due-long conserved region 3  of the Ets domain (28). Fli-1, 
like Ets-1 and Ets-2, contains a lysine at this position, yet it 
has a strict requirement for a GGAA core motif, suggesting 
that  other  residues  within  this  region  also  influence  the 
specificity of DNA binding.  Since  the binding sites  for all 
these proteins  are related,  fine binding specificity may also 
be  influenced  by specific  interactions  with  accessory pro- 
teins (5-13). 
Optimal  Elf-1  Sites Are  Not Present in Any Known Elf-1 
Regulated Promoters.  A  comparison of all known Elf-1 sites 
(Table 2) with the consensus defined in this report revealed 
that none of the known Elf-1 sites  conform to the optimal 
sequence  (Table  2),  and  a  BLAST  computer  search  (29) 
failed to identify any promoters with an optimal Elf-1  site. 
We  have  demonstrated  that  in Jurkat  cells,  a  high  affinity 
Elf-1 site may confer less inducibility to a gene than a lower 
affinity  site  which  may  efficiently  bind  Elf-1  only in  the 
context of other transcription factors that bind to adjacent 
sites.  The  absence  of a  high  affinity Elf-1  site  among the 
known Elf-1 sites  could therefore represent a mechanism to 
conserve juxtaposed DNA binding sites  for cofactors, capa- 
ble of modulating Elf-1 binding and transcriptional activity, 
as well  as preventing  efficient  binding of other Ets  family 
proteins such as ERGB/Fli-1. Our findings suggest that the 
stable  binding  of Elf-1  to  its  cognate  site  in  the  IL-2Rot 
promoter is influenced by protein-protein  interactions with 
other protein(s),  as  has  been  demonstrated  with  the  IL-3 
(5)  and GM-CSF  (6)  genes which also have nonconsensus 
Elf-1  binding  sites.  As  the  hst  of genes  recognized  to  be 
regulated by Elf-1  continues to grow, it will be important 
to determine the range of cofactors that facilitate Elf-1 bind- 
ing and/or activation via imperfect sites. 
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